| 摘要: |
| 凝血酶是凝血瀑布中的重要位点,在止血与凝血中扮演着重要角色。凝血酶与血小板膜受体GPIb-Ⅸ-Ⅴ结合可以介导血小板活化,促进血栓生成。本文通过查阅相关文献,对凝血酶和GPIb-Ⅸ-Ⅴ受体的结构、作用机制进行相关介绍,并将近年来针对凝血酶和GPIb-Ⅸ-Ⅴ受体为治疗靶点的新型抗血栓制剂进行综述,期望对血栓治疗提供新思路。 |
| 关键词: 凝血酶 GPIb-IX-V受体 新型抗血栓制剂 |
| DOI:10.13506/j.cnki.jpr.2017.03.009 |
| 基金项目:国家自然科学基金(No.81373415) |
|
|
|
| Research progress on thrombin binding of GPIb-Ⅸ-Ⅴ complex and related drugs |
| CUI Shuang,GONG Guoqing |
| (Department of Pharmacology,China Pharmaceutical University,Nanjing 211198,China) |
| Abstract: |
| Thrombin,a key factor of the coagulation cascade,plays an important role on hemostasis and coagulation.Thrombin binding to platelet membrane receptor GPIb-Ⅸ-Ⅴ can mediate platelet activation and promote thrombosis.By reviewing the relevant literatures,we introduce the structure of thrombin and GPIb-Ⅸ-Ⅴ complex and the mechanisms of its interaction.Moreover,this paper reviewed the latest study progress of novel anti-thrombotic agents targeting on thrombin or GPIb-Ⅸ-Ⅴ to provide new ideas for thrombus therapy. |
| Key words: Thrombin GPIb-Ⅸ-Ⅴ complex Novel anti-thrombotic agents |